6-fluoro-3-tyrosine has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankiewicz, KS; Eberling, JL; Emborg, ME; Nagy, D; Oiwa, Y; Pivirotto, P | 1 |
| Bankiewicz, KS; Bringas, J; Eberling, JL; Pivirotto, P | 1 |
2 other study(ies) available for 6-fluoro-3-tyrosine and Parkinsonian Disorders
| Article | Year |
|---|---|
Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Carotid Arteries; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Histocytochemistry; Humans; Injections, Intra-Arterial; Macaca mulatta; Male; Neurochemistry; Parkinson Disease, Secondary; Parkinsonian Disorders; Tomography, Emission-Computed; Tyrosine; Tyrosine 3-Monooxygenase | 2003 |
Comparison of two methods for the analysis of [18F]6-fluoro-L-m-tyrosine PET data.
Topics: Animals; Cerebellum; Corpus Striatum; Dominance, Cerebral; Dopamine; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Macaca mulatta; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Statistics as Topic; Tyrosine | 2004 |